05B4 Lu, Bo - Thomas Jefferson University - Thomas Jefferson University
248D
bxl017

Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. Heat shock protein 90 inhibition: Rationale and clinical potential
  2. Role of insulin-like growth factor-1 signaling pathway in cisplatin-resistant lung cancer cells
  3. The zinc ionophore PCI-5002 radiosensitizes non-small cell lung cancer cells by enhancing autophagic cell death
  4. MLN8054, A small molecule inhibitor of Aurora kinase A, sensitizes androgen-resistant prostate cancer to radiation
  5. Editorial: Cancer stem cells
  6. No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes
  7. The matrix metalloproteinase-7 polymorphism RS10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer
  8. Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated aurora kinase B inhibition
  9. Inhibition of JAK2 signaling by TG101209 enhances radiotherapy in lung cancer models
  10. Terameprocol (tetra-o-methyl nordihydroguaiaretic acid), an inhibitor of Sp1-mediated survivin transcription, induces radiosensitization in non-small cell lung carcinoma
  11. Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis
  12. Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation
  13. Endoplasmic reticulum stress mediates radiation-induced autophagy by perk-eIF2α in caspase-3/7-deficient cells
  14. Progress in the unraveling of the endoplasmic reticulum stress/autophagy pathway and cancer: Implications for future therapeutic approaches
  15. AT-101, a Pan-Bcl-2 inhibitor, leads to radiosensitization of non-small cell lung cancer
  16. The EGFR Polymorphism rs884419 is Associated With Freedom From Recurrence in Patients With Resected Prostate Cancer
  17. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer
  18. Prognostic factors for resected non-small cell lung cancer with pN2 status: Implications for use of postoperative radiotherapy
  19. HSP90 inhibitors: Multi-targeted antitumor effects and novel combinatorial therapeutic approaches in cancer therapy
  20. Combined Bcl-2/mammalian target of rapamycin inhibition leads to enhanced radiosensitization via induction of apoptosis and autophagy in non-small cell lung tumor xenograft model
0